Association of Head Injury with Brain Amyloid Deposition: The ARIC-PET Study
- PMID: 30963804
- PMCID: PMC6909743
- DOI: 10.1089/neu.2018.6213
Association of Head Injury with Brain Amyloid Deposition: The ARIC-PET Study
Abstract
Our objective was to examine associations of head injury with total and regional brain amyloid deposition. We performed cross-sectional analyses of 329 non-demented participants (81 with prior head injury) in the Atherosclerosis Risk in Communities-Positron Emission Tomography (ARIC-PET) Study who underwent 18-florbetapir PET imaging in 2012-2014. A history of head injury was defined by self-report or emergency department/hospitalization International Classification of Diseases, Ninth Revision codes. Generalized linear regression models adjusted for demographic, socioeconomic, and dementia/cardiovascular risk factors were used to estimate prevalence ratios (PRs; 95% confidence intervals [CIs]) for elevated (> 1.2) global and regional standard uptake value ratios (SUVRs). Mean age of participants was 76 years, 57% were women, and 43% were black. Head injury was associated with increased prevalence of elevated SUVR >1.2 globally (PR: 1.31; 95% CI: 1.19-1.57), as well as in the orbitofrontal cortex (PR: 1.23); (95% CI: 1.04-1.46), prefrontal cortex (PR: 1.18; 95% CI: 1.00-1.39), superior frontal cortex (PR: 1.24; 95% CI: 1.05-1.48), and posterior cingulate (PR: 1.26; 95% CI: 1.04-1.52). There also was evidence for a dose-response relationship, whereby a history of ≥1 head injury was associated with elevated SUVR >1.2 in the prefrontal cortex and superior frontal cortex compared with persons with a history of one head injury (all, p < 0.05). In conclusion, head injury was associated with increased amyloid deposition globally and in the frontal cortex and posterior cingulate, with suggestion of a dose-response association of head injuries with beta-amyloid deposition. Further work is needed to determine if increased amyloid deposition contributes to dementia in this population.
Keywords: PET amyloid imaging; cohort study; epidemiology; head injury.
Conflict of interest statement
Dr. Ling serves as a consultant on the BrainScope Scientific Advisory Board (unpaid position), the National Football League Players Association Mackey-White Health Committee (unpaid position), the National Football League Health Foundation, the National Institutes of Health National Center for Advancing Transitional Sciences, and the Veterans Administration Research Advisory Council.
For the other authors, no competing financial interests exist.
Figures

Similar articles
-
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.JAMA. 2017 Apr 11;317(14):1443-1450. doi: 10.1001/jama.2017.3090. JAMA. 2017. PMID: 28399252 Free PMC article.
-
Association of Surgical Hospitalization with Brain Amyloid Deposition: The Atherosclerosis Risk in Communities-Positron Emission Tomography (ARIC-PET) Study.Anesthesiology. 2020 Jun;132(6):1407-1418. doi: 10.1097/ALN.0000000000003255. Anesthesiology. 2020. PMID: 32412719 Free PMC article.
-
Tau Positron-Emission Tomography in Former National Football League Players.N Engl J Med. 2019 May 2;380(18):1716-1725. doi: 10.1056/NEJMoa1900757. Epub 2019 Apr 10. N Engl J Med. 2019. PMID: 30969506 Free PMC article.
-
Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC-PET Study.J Am Heart Assoc. 2020 Dec 15;9(24):e018399. doi: 10.1161/JAHA.120.018399. Epub 2020 Dec 8. J Am Heart Assoc. 2020. PMID: 33289449 Free PMC article.
-
Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study.JAMA Neurol. 2020 Mar 1;77(3):350-357. doi: 10.1001/jamaneurol.2019.4339. JAMA Neurol. 2020. PMID: 31860001 Free PMC article.
Cited by
-
Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.J Neurol. 2022 Feb;269(2):873-884. doi: 10.1007/s00415-021-10669-5. Epub 2021 Jun 30. J Neurol. 2022. PMID: 34191080
-
Brain Trauma Imaging.J Nucl Med. 2023 Jan;64(1):20-29. doi: 10.2967/jnumed.121.263293. J Nucl Med. 2023. PMID: 36599475 Free PMC article.
-
From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration.Front Neurol. 2025 Aug 5;16:1637243. doi: 10.3389/fneur.2025.1637243. eCollection 2025. Front Neurol. 2025. PMID: 40837059 Free PMC article. Review.
-
How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.J Alzheimers Dis. 2023;92(1):183-193. doi: 10.3233/JAD-220658. J Alzheimers Dis. 2023. PMID: 36710672 Free PMC article.
-
Association of remote mild traumatic brain injury with cortical amyloid burden in clinically normal older adults.Brain Imaging Behav. 2021 Oct;15(5):2417-2425. doi: 10.1007/s11682-020-00440-1. Epub 2021 Jan 11. Brain Imaging Behav. 2021. PMID: 33432536 Free PMC article.
References
-
- Roozenbeek B., Maas A.I., and Menon D.K. (2013). Changing patterns in the epidemiology of traumatic brain injury. Nat. Rev. Neurol. 9, 231–236 - PubMed
-
- Centers for Disease Control and Prevention (2015). Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. National Center for Injury Prevention and Control: Atlanta, GA - PubMed
-
- Mendez M.F. (2017). What is the relationship of traumatic brain injury to dementia? J Alzheimers Dis. 57, 667–681 - PubMed
-
- Griesbach G.S., Masel B.E., Helvie R.E., and Ashley M.J. (2018). The impact of traumatic brain injury on later life: effects on normal aging and neurodegenerative diseases. J. Neurotrauma 35, 17–24 - PubMed
-
- Wang H.K., Lin S.H., Sung P.S., Wu M.H., Hung K.W., Wang L.C., Huang C.Y., Lu K., Chen H.J., and Tsai K.J. (2012). Population based study on patients with traumatic brain injury suggests increased risk of dementia. J. Neurol. Neurosurg. Psychiatry 83, 1080–1085 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- U01 HL096812/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- U01 HL096902/HL/NHLBI NIH HHS/United States
- R01 AG040282/AG/NIA NIH HHS/United States
- P30 AG049638/AG/NIA NIH HHS/United States
- U01 HL096814/HL/NHLBI NIH HHS/United States
- K24 AG052573/AG/NIA NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- R25 NS065729/NS/NINDS NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- K24 DK106414/DK/NIDDK NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- R01 HL070825/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- U01 HL096899/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials